|
LOC148189 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.14550036123262E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
4.740000E-02 |
| Stage1-vs-Stage3 |
4.179000E-01 |
| Stage1-vs-Stage4 |
3.143600E-02 |
| Stage2-vs-Stage3 |
2.089700E-02 |
| Stage2-vs-Stage4 |
1.117170E-03 |
| Stage3-vs-Stage4 |
1.701170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.29839999652282E-08 |
| Normal-vs-Asian |
9.99200722162641E-16 |
| Caucasian-vs-AfricanAmerican |
2.754400E-01 |
| Caucasian-vs-Asian |
9.391200E-01 |
| AfricanAmerican-vs-Asian |
3.152600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.944600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62725388719309E-12 |
| Normal-vs-Age(81-100Yrs) |
1.014790E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.350600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.210800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.968200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.365200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.369200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.755400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.059600E-03 |
| Classical-VS-Follicular |
8.802600E-03 |
| Classical-VS-Other |
4.125600E-01 |
| Classical-VS-Normal |
1.62481139653892E-12 |
| Tall-VS-Follicular |
1.55378999999733E-05 |
| Tall-VS-Other |
1.801170E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
8.802800E-01 |
| Follicular-VS-Normal |
1.26749721829356E-11 |
| Other-VS-Normal |
1.383270E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11022302462516E-16 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.202200E-03 |
|
|
